Palmerston North, New Zealand

Kate Hill


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Kate Hill in Palmerston North, NZ

Introduction

Kate Hill is an innovative inventor based in Palmerston North, New Zealand. With a keen focus on therapeutic advancements, she has made significant contributions to the field of medicine. Her expertise and dedication have led to the development of a unique patent that enhances the administration of antihyperthyroid drugs.

Latest Patents

Kate holds a patent for a topical formulation that relates to composition and therapeutic methods involving at least one antihyperthyroid drug formulated for transdermal administration. This innovative formulation offers a more convenient method of administration compared to existing oral formulations used in animals. Furthermore, it addresses key issues surrounding transdermal versus oral administration by ensuring stability during storage while maintaining a high level of efficacy.

Career Highlights

In her professional journey, Kate has gained recognition not only for her groundbreaking patent but also for her commitment to advancing medical treatments. Her work at Bayer Intellectual Property GmbH reflects her commitment to innovation in the pharmaceutical industry. Her contributions are paving the way for more effective and user-friendly drug administration methods.

Collaborations

Kate has collaborated with talented colleagues, including Karthigeyan Nanjan and Fadil Al Alawi. Together, they have fostered a creative and productive environment that enhances research and development efforts within their company. This teamwork is crucial for driving further innovations in the field.

Conclusion

Kate Hill exemplifies the spirit of innovation and creativity in the realm of therapeutics. With her patented transdermal formulation, she is reshaping the way antihyperthyroid drugs are administered, ultimately leading to better health outcomes. As she continues her work at Bayer Intellectual Property GmbH, the future of her contributions to the medical field appears promising and impactful.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…